Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Galera Therapeutics ( (GRTX) ) is now available.
On May 15, 2026, Galera Therapeutics, Inc. converted its remaining 42,839.11 shares of Series B Non-Voting Convertible Preferred Stock into 42,839,103 shares of common stock in accordance with its governing certificate of designation. The company opted to settle any fractional share entitlements in cash based on the trading value at the close of business on the conversion date, leaving no Series B Preferred Stock outstanding and simplifying its capital structure for shareholders.
This mandatory conversion effectively eliminates the preferred share class, consolidating Galera’s equity into a single common stock base. The move may streamline the company’s governance and capital structure, potentially improving transparency for investors and aligning all equity holders within the same class of securities.
Spark’s Take on GRTX Stock
According to Spark, TipRanks’ AI Analyst, GRTX is a Neutral.
The score is primarily constrained by very weak financial performance (pre-revenue, ongoing operating losses, and historically negative free cash flow) despite a notable 2025 deleveraging. Technicals are constructive but appear overbought, while corporate events improve funding outlook via the Obsidian merger/financing but come with meaningful dilution/ownership reduction and potential reverse-split considerations.
To see Spark’s full report on GRTX stock, click here.
More about Galera Therapeutics
Galera Therapeutics, Inc. operates in the biopharmaceutical industry, focusing on the development of therapeutic products, with its capital structure including both common stock and previously issued Series B Non-Voting Convertible Preferred Stock. The company accesses equity markets through different share classes as part of its financing and ownership framework.
Average Trading Volume: 332,092
Technical Sentiment Signal: Buy
Current Market Cap: $16.05M
See more insights into GRTX stock on TipRanks’ Stock Analysis page.